The Department of Commerce recently held an invitation-only meeting in order to reach out to industry to discuss international climate change negotiations. Numerous governmental agencies are involved in
China Aoxing has received renewal of the Good Manufacturing Practice (GMP) certification for its capsule formulation and packaging production facility. Reportedly, the certificate of compliance has a five-year
Promedior has initiated phase 1 clinical trial of PRM-151, a novel compound in development for the treatment of fibrotic diseases and tissue remodeling. The phase 1 dose escalation
Following the review of the available evidence on Sanofi-aventis’ Lantus (insulin glargine [rDNA] injection), the European Medicines Agency’ Committee for Medicinal Products for Human Use (CHMP) has confirmed
Regeneron has reported the enrollment of the first patient in the phase 3 program of VEGF Trap-Eye, for the treatment of central retinal vein occlusion (CRVO). Regeneron has
Arno Therapeutics has initiated dosing of the first patient in a phase II clinical study of AR-67 in adult patients with myelodysplastic syndrome (MDS), who have failed prior
PolyMedix and the University of Massachusetts have bagged a phase I Small Business Technology Transfer (STTR) contract, to support research to identify lead antimicrobial compounds against bacterial pathogens.
Speharm, Access’ European partner, is collecting data from a post approval study of MuGard in head and neck cancer patients, undergoing radiation treatment in the UK showing prevention
The Siemens booth at this year’s 2009 AACC will feature a number of Siemens newest instruments and assays, including: Dimension EXL with LM (LOCI module) System Dimension Vista
Merz has reported that new XEOMIN (Botulinum neurotoxin type A) is now available in Canada. The drug would be prescribed to patients with Blepharospasm, Cervical Dystonia and Post-Stroke
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.